July 18, 2016
Bach Pharma Inc. (North Andover, MA) has appointed Kelly Blackburn as Chief Executive Officer.
Kelly Blackburn
Ms. Blackburn was previously Vice President of Clinical Affairs at aTyr Pharma (San Diego, CA). Prior to that she was at Vertex Pharmaceuticals.
Ms. Blackburn is tasked with leading Bach Pharma as it brings its lead candidate, GVT, into the clinic.
The company also announced that Mark O. Henry will serve as Chief Financial Officer, transitioning from his role as CEO.
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.